Navigation Links
MHA Announces Pegeen Butterfield, RN as Senior Vice President of Trade Relations

FLORHAM PARK, N.J., Jan. 6 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA) is pleased to announce that Pegeen Butterfield, RN, has joined MHA, Inc. as the new Senior Vice President of Trade Relations. In this newly created role Pegeen will have executive responsibility for all contracting functions and all wholesaler business partnerships. Michael J. Sicilian, President of MHA, commented, "The creation of this new role within our organization is directly related to the significant growth we have experienced over the last several years. By combining all contracting functions under Pegeen, we will be able to continue to strategically build stronger business partnerships and provide more value for the members we serve."

Pegeen joins MHA after spending the last 9 years working for Medco Health Solutions. Most recently she worked directly with the executive management team focusing on strategic partnerships, leveraging prescription data and developing employer solutions for onsite pharmacy and medical clinics. Previous roles at Medco included provider relations and strategic alliances within Medco's retail network division focusing on retail specialty pharmacy strategy, and development of a Long Term Care Network for Medicare Part D. Her background also includes extensive medical insurance experience in medical policy, utilization management and case management, including creation of a care management subsidiary of Blue Cross Blue Shield. She began her career as a nurse with a focus on rehabilitation medicine specializing in traumatic brain injury. Pegeen's unique combination of skills in relationship management, building creative partnerships, clinical expertise and a diverse healthcare view will allow her to make a major contribution to MHA's continue growth. Added Pegeen, "I am thrilled to be joining the largest alternate site GPO in the country. By creating this role, MHA has demonstrated its commitment to developing new contracting strategies, engaging our wholesaler business partners at the executive level and continuing to bring value to our membership."

Managed Health Care Associates, Inc. (MHA) is the market leading Alternate Site GPO and Long Term Care Pharmacy Network Manager servicing the Independent LTC Pharmacy Industry. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create innovative, customized, web tools and reports, designed to increase savings and promote profitability. Members utilize MHA's services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and food, as well as, network access to the majority of the largest national and regional prescription drug plans managing the Medicare Part D drug benefit. MHA also offers a variety of services to medical supply, pharmaceutical manufacturers and prescription drug plan organizations, including contract administration, marketing, and continuing education. For more information, visit

    For More Information Contact: Angela Elsier
    Director of Marketing
    Managed Health Care Associates, Inc.
    800-642-3020 X 2870

SOURCE Managed Health Care Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IMRIS announces first IMRISneuro project in Australia
2. Akrimax Pharmaceuticals Announces Manufacturing Partnership
3. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
4. American Asthma Foundation Announces Breakthrough Discovery
5. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
6. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
7. DiFUSION Technologies Announces Company Launch Focused on Surgical Site Infections (SSIs)
8. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
9. B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking"
10. Alfacell Announces Receipt of NASDAQ Panel Decision
11. Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: